← Open Payments lookup

TROY HENDERSON: Open Payments

NPI 1609324003 · FULTONDALE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,929 in 153 payments from 29 companies in 2025. Trend: 2023 $3,685 · 2024 $4,505 · 2025 $2,929

Food & beverage: $2,929
CompanyPaymentsAmount
GlaxoSmithKline, LLC.14$368
ABBVIE INC.27$352
AstraZeneca Pharmaceuticals LP16$341
Novo Nordisk Inc14$238
Amgen Inc.9$174
Bayer Healthcare Pharmaceuticals Inc.9$162
Lilly USA, LLC8$145
PFIZER INC.7$140
Axsome Therapeutics, Inc.5$117
Takeda Pharmaceuticals U.S.A., Inc.6$111

Products named: TRELEGY ELLIPTA, Kerendia, VRAYLAR, UBRELVY, JARDIANCE, FARXIGA, Ozempic, Auvelity.

Industry payments across AL — which companies pay providers there.